GLUCOCORTICOID-REFRACTORY AGVHD

Clinical trials for GLUCOCORTICOID-REFRACTORY AGVHD explained in plain language.

Never miss a new study

Get alerted when new GLUCOCORTICOID-REFRACTORY AGVHD trials appear

Sign up with your email to follow new studies for GLUCOCORTICOID-REFRACTORY AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill tested for Life-Threatening transplant complication

Disease control Completed

This study tested a new oral medication called TQ05105 for patients with a severe complication of stem cell transplants called acute graft-versus-host disease (aGVHD) that does not respond to standard steroid treatment. The main goals were to check the drug's safety, how well the…

Matched conditions: GLUCOCORTICOID-REFRACTORY AGVHD

Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

GLUCOCORTICOID-REFRACTORY AGVHD

Get alerted when new GLUCOCORTICOID-REFRACTORY AGVHD trials appear

New pill tested for Life-Threatening transplant complication